Samraat S. Raha Myriad Genetics Inc (MYGN) insider trading activity

Samraat S. Raha is President and CEO of MYRIAD GENETICS INC. Currently has a direct ownership of 482,738 shares of MYGN, which is worth approximately $2.33 Million. The most recent transaction as insider was on May 31, 2025, when has been sold 1,498 shares (Common Stock) at a price of $3.56 per share, resulting in proceeds of $5,332. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 483K

0.31% 3M change

60.46% 12M change

Total Value Held $2.33 Million

Samraat S. Raha Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 31 2025	BUY Grant, award, or other acquisition	$5,332 $3.56 p/Share	1,498 Added 0.31%	482,738 Common Stock
Mar 14 2025	SELL Payment of exercise price or tax liability	$77,025 $10.07 p/Share	7,649 Reduced 1.56%	481,240 Common Stock
Mar 13 2025	BUY Grant, award, or other acquisition	-	216,495 Added 30.69%	488,889 Common Stock
Dec 11 2024	SELL Payment of exercise price or tax liability	$429,176 $14.51 p/Share	29,578 Reduced 9.79%	272,394 Common Stock
Nov 30 2024	BUY Grant, award, or other acquisition	$15,461 $13.83 p/Share	1,118 Added 0.37%	301,972 Common Stock
Mar 14 2024	BUY Grant, award, or other acquisition	-	64,494 Added 17.65%	300,854 Common Stock
Dec 11 2023	BUY Grant, award, or other acquisition	-	236,360 Added 50.0%	236,360 Common Stock

Also insider at

AGILENT TECHNOLOGIES, INC. Healthcare

Sr. Vice President

SSR

Samraat S. Raha

President and CEO

Santa Clara, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MYGN shares.

Notify only if

Value

Insider Trading

Get notified when an Myriad Genetics Inc insider buys or sells MYGN shares.

Notify only if

Operation

Value

Type

News

Receive news related to MYRIAD GENETICS INC

Track Activities on MYGN

Account